Recurring digestive issues like bloating, abdominal pain, or alternating diarrhoea and constipation can significantly impact daily life. To address these discomforts at their source, Kijimea IBS Pro offers an innovative, clinically validated solution designed to restore intestinal balance. This targeted medical device uses a unique scientific approach to soothe irritable bowel syndrome (IBS) symptoms and promote lasting digestive comfort.
A targeted reparative action
The key to Kijimea’s effectiveness lies in its exclusive strain of bifidobacteria—B. bifidum HI-MIMBb75—carefully selected for its protective properties. This strain acts like an intestinal bandage, adhering to the mucosal lining to support its natural regeneration. By repairing the microlesions responsible for inflammation and hypersensitivity, it significantly reduces functional digestive disturbances and helps restore balanced bowel movements.
Unlike symptomatic treatments, this medical device targets the root cause of imbalance, delivering gradual and sustained improvement. Clinical studies demonstrate a marked reduction in typical IBS symptoms, with excellent long-term tolerability.
Proven efficacy and validated safety
The effectiveness of IBS Pro has been rigorously assessed in a randomised clinical trial, published in The Lancet Gastroenterology & Hepatology. Results confirm its beneficial impact on reducing abdominal pain, bloating, and bowel irregularities, with an impeccable safety profile. As a medical device, it is designed for easy daily integration, with no interactions with ongoing treatments.
Manufactured to the highest standards, it meets all medical device requirements and carries CE marking, ensuring compliance and safety. Regular use helps restore optimal digestive comfort and quality of life, without dependency.
With Kijimea, choose a scientifically backed solution to soothe your gut and regain daily serenity and well-being.
Kijimea® IBS Pro – Medical device for the treatment of irritable bowel syndrome (IBS), addressing typical symptoms of constipation, diarrhoea, abdominal pain, and bloating.
Clinically proven efficacy in cases of irritable bowel syndrome[1]
[1] Andresen V. et al. (2020): Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial. Lancet Gastroenterol Hepatol. 2020; 5: 658-666.
